 Myeloablative therapy unpurged autologous bone marrow transplantation poor-prognosis neuroblastoma report cases October November patients year month years months resistant neuroblastoma NB group patients unselected NB group patients disseminated NB group patients myeloablative therapy MAT unpurged autologous bone marrow transplantation ABMT end intensive protocol high-dose chemotherapy surgery primary tumor Median time diagnosis MAT ABMT months months last relapse MAT ABMT relapsed patients MAT regimen vincristine total body irradiation TBI melphalan Seventeen patients complete remission CR good partial remission VGPR partial remission PR progressive disease PD acute toxic death rate overall progression-free survival median progression-free survival months patients CR months patients VGPR months patients PR